StockWatch: Amgen Throws Its Weight Behind Obesity Drug
Amgen enjoyed its biggest one-day stock gain since 2009 after top executives delivered positive comments about its obesity candidate MariTide.
Amgen enjoyed its biggest one-day stock gain since 2009 after top executives delivered positive comments about its obesity candidate MariTide.
7 questions for Sandy Leonard, chief commercial officer at RWD vendor, COTA.
Put the Public in the Driver’s Seat: Shadow Report to the US Senate AI Policy Roadmap
Researchers at the University of Illinois say low-cost, wearable sensors could increase access to care for Parkinson’s disease patients.
Nature Biotechnology – A confocal microscopy technique enables high-resolution intravital imaging over multiple hours.
Min Peng and his team used the CAR T technology to successfully treat not cancer, but chronic asthma using a mouse model.
The partnership will add single-cell RNA profiling to Integrated Biosciences’ synthetic biology and AI-driven drug discovery engine.
Neurodevelopmental conditions, such as autism, and mental illness, such as schizophrenia and bipolar disorder, are very common. However, the underlying mechanisms of these disorders remain…
Analysis of cell-type composition from 1270 brains across three diagnoses implicates endothelial cell loss in Alzheimer’s disease.
In 2,160 postmortem brain samples from adults with psychiatric disorders, females showed greater transcriptomic burden and connectivity variability than did males.
The complexity and heterogeneity of schizophrenia have hindered mechanistic elucidation and the development of more effective therapies. Here, we performed single-cell dissection of schizophrenia-associated transcriptomic…